Allarity Therapeutics (ALLR) Misses Q2 EPS by 15c

Allarity Therapeutics (NASDAQ: ALLR) reported Q2 EPS of ($0.15).

For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.

You May Also Be Interested In

• Scribe Therapeutics files for proposed Nasdaq IPO
• Lockheed Martin (LMT) In Lead To Buy Ultra Maritime For ~$3.5B - FT
• Jane Street discloses 5% passive stake in Hertz Global